Sorting out the varying standards for pharmacoeconomic guidelines
By Kevin Frick (kevin.frick@rxcomms.com) As we provide and interpret pharmacoeconomic (PE) evaluation results for decision makers in different settings around the world, we should consider the standards being followed. And…
Details